13 results
424B5
HUGE
FSD Pharma Inc - Ordinary Shares
16 Feb 24
Prospectus supplement for primary offering
6:36pm
attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and reduced disclosure obligations regarding executive compensation (to the extent
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
24 May 22
FSD Pharma Inc. 6-K
9:24am
flexibility to its executive compensation program, the Company adopted an equity incentive plan on May 16, 2022 (the “EIP”) pursuant to which it may grant
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
23 May 22
Annual General Meeting of the Shareholders
4:29pm
or affiliate of any such persons, in any matter to be acted upon at the Meeting.
- 27 -
STATEMENT OF EXECUTIVE COMPENSATION
Compensation Discussion … and the reasons for their compensation. For a complete understanding of the executive compensation program, this disclosure should be read in conjunction
20-F
l8x5y0lm xozw
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
ll7bs mvx7cadisf
5 May 21
Current report (foreign)
11:30am
6-K
EX-99.1
z4bad0
23 Apr 21
Current report (foreign)
5:24pm
40FR12B
EX-99.36
gsbruuuw
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.17
zn9u5bs77e
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.45
lri0hiilt9 jkc3u
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.7
rbsp4y idtfn2et
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.28
uioj11q5pv
6 Dec 19
Initial registration of securities (Canada)
12:28pm
- Prev
- 1
- Next